These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 31983061)

  • 21. Precision medicine: lessons learned from the SHIVA trial.
    Tsimberidou AM; Kurzrock R
    Lancet Oncol; 2015 Dec; 16(16):e579-80. PubMed ID: 26678197
    [No Abstract]   [Full Text] [Related]  

  • 22. Precision medicine beyond medical oncology: using molecular analysis to guide treatments of colorectal neoplasia.
    Molloy MP; Engel A
    Expert Rev Gastroenterol Hepatol; 2018 Dec; 12(12):1179-1181. PubMed ID: 30791786
    [No Abstract]   [Full Text] [Related]  

  • 23. A precision, personalized approach to the management of bladder cancer.
    Apolo AB; Burger M
    Curr Opin Urol; 2015 Sep; 25(5):416-7. PubMed ID: 26153639
    [No Abstract]   [Full Text] [Related]  

  • 24. Precision medicine: lessons learned from the SHIVA trial - Authors' reply.
    Le Tourneau C; Belin L; Paoletti X; Bièche I; Kamal M
    Lancet Oncol; 2015 Dec; 16(16):e581-2. PubMed ID: 26678200
    [No Abstract]   [Full Text] [Related]  

  • 25. Expansion platform type II: testing a treatment strategy.
    Catenacci DV
    Lancet Oncol; 2015 Oct; 16(13):1276-8. PubMed ID: 26342235
    [No Abstract]   [Full Text] [Related]  

  • 26. Delivering on the promise of precision cancer medicine.
    Berger MF; Van Allen EM
    Genome Med; 2016 Oct; 8(1):110. PubMed ID: 27782852
    [No Abstract]   [Full Text] [Related]  

  • 27. Fusions in solid tumours: diagnostic strategies, targeted therapy, and acquired resistance.
    Schram AM; Chang MT; Jonsson P; Drilon A
    Nat Rev Clin Oncol; 2017 Dec; 14(12):735-748. PubMed ID: 28857077
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Brave-ish New World--What's Needed to Make Precision Oncology a Practical Reality.
    MacConaill LE; Lindeman NI; Rollins BJ
    JAMA Oncol; 2015 Oct; 1(7):879-80. PubMed ID: 26181886
    [No Abstract]   [Full Text] [Related]  

  • 29. New ESMO scale ranks mutations as cancer medicine targets.
    Fricker J
    Lancet Oncol; 2018 Oct; 19(10):e513. PubMed ID: 30177495
    [No Abstract]   [Full Text] [Related]  

  • 30. Anticipating designer drug-resistant cancer cells.
    Frangione ML; Lockhart JH; Morton DT; Pava LM; Blanck G
    Drug Discov Today; 2015 Jul; 20(7):790-3. PubMed ID: 25697478
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Maurie Markman on the Groundbreaking TAPUR Trial.
    Markman M
    Oncology (Williston Park); 2017 Mar; 31(3):158, 168. PubMed ID: 28299751
    [No Abstract]   [Full Text] [Related]  

  • 32. Targeted therapy in cancer.
    Tsimberidou AM
    Cancer Chemother Pharmacol; 2015 Dec; 76(6):1113-32. PubMed ID: 26391154
    [TBL] [Abstract][Full Text] [Related]  

  • 33. How Imaging Biomarkers Can Inform Clinical Trials and Clinical Practice in the Era of Targeted Cancer Therapy.
    Farwell MD; Clark AS; Mankoff DA
    JAMA Oncol; 2015 Jul; 1(4):421-2. PubMed ID: 26181243
    [No Abstract]   [Full Text] [Related]  

  • 34. Drug sensitivity testing platforms for gastric cancer diagnostics.
    Lau V; Wong AL; Ng C; Mok Y; Lakshmanan M; Yan B
    J Clin Pathol; 2016 Feb; 69(2):93-6. PubMed ID: 26567318
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A decision support framework for genomically informed investigational cancer therapy.
    Meric-Bernstam F; Johnson A; Holla V; Bailey AM; Brusco L; Chen K; Routbort M; Patel KP; Zeng J; Kopetz S; Davies MA; Piha-Paul SA; Hong DS; Eterovic AK; Tsimberidou AM; Broaddus R; Bernstam EV; Shaw KR; Mendelsohn J; Mills GB
    J Natl Cancer Inst; 2015 Jul; 107(7):. PubMed ID: 25863335
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Cancer: three eras of personalized medicine].
    Jordan B
    Med Sci (Paris); 2017 Oct; 33(10):905-908. PubMed ID: 28994388
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fantastic voyage: the future of cancer diagnostics.
    Sundaresan TK; Haber DA
    Lancet Oncol; 2015 Dec; 16(16):1596-8. PubMed ID: 26678190
    [No Abstract]   [Full Text] [Related]  

  • 38. Personalising the treatment of prostate cancer.
    Gunjur A
    Lancet Oncol; 2015 Dec; 16(16):e592. PubMed ID: 26549591
    [No Abstract]   [Full Text] [Related]  

  • 39. Ovarian cancer: targeting the untargetable.
    Birrer MJ
    Am Soc Clin Oncol Educ Book; 2014; ():13-5. PubMed ID: 24857054
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The RACE to Develop New Targeted Therapies for Children With CNS Tumors.
    Fletcher EP; Burckart GJ; Robinson GW; Reaman GH; Stewart CF
    Clin Pharmacol Ther; 2020 Sep; 108(3):434-436. PubMed ID: 32638364
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.